BTIG analyst Julian Harrison downgraded Outlook Therapeutics Inc. (NASDAQ: OTLK) from Buy to Neutral.The analyst comments "We are downgrading OTLK ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Downgrades